Skip to main content
. 2023 Feb 24;9(3):e13763. doi: 10.1016/j.heliyon.2023.e13763

Table 1.

Number of COVID-19 clinical trials that includes anticoagulant drugs [6].

Total
Recruiting Completed Not yet
Active, not
trials recruiting recruiting
Heparin 112a 36 41 14 3
Warfarin 1 0 1 0 0
Dabigatran 3 1 2 0 0
Rivaroxaban b19 8 6 1 0
Apixaban 11 6 2 1 1
Edoxaban 3 2 1 0 0
a

2 CTs is enrolling by invitation, 5 CTs having got terminated, and 4 CTs withdrawn.

b

3 CTs having got terminated.